Posters

Combined LASIK and a transparent shape-changing corneal inlay with mitomycin C (MMC)

Poster Details

First Author: J.Theng SINGAPORE

Co Author(s):    H. Choi   S. Chng   S. Zhi Da              

Abstract Details

Purpose:

To evaluate the safety and efficacy of concurrent LASIK and Raindrop corneal inlay implantation with the application of 0.02% MMC.

Setting:

Eagle Eye CentreSingapore

Methods:

Femtosecond LASIK was performed on patients�â�€�™ non-dominant eye to achieve a �.75 D refraction. MMC at 0.02% was applied to the stromal bed and the flap�â�€�™s stromal surface for 15 seconds before washing with BSS. The Raindrop Inlay was then placed onto a dry corneal stromal bed. Post-surgery evaluation included monocular safety measurements: best-corrected visual acuities (BCVA), endothelial cell counts (ECC), anterior ocular health and efficacy measurements: UCVA at near and distance, MRSE, and satisfaction.

Results:

23patients with a mean age of 47(range 38�â�€�“56) and mean reading addition of 1.45D(range 0�â�€�“2.25 D) were studied. At preop, mean UCNVA was 0.23,by 6 months(N=17), mean UCNVA improved to 0.68.89% of patients see 0.6 or better at near in inlay eye.There was little change in uncorrected distance visual acuity at 6 months. Average change in ECC in inlay eye was not statistically different (preop: 2745vs6M:2626,p=0.11).Majority of subjects were clear with no central corneal haze, 1 subject developed mild corneal haze that resolved with second round of steroids. 94% of patients were satisfied with their inlay at 6months.

Conclusions:

The Raindrop Near Vision Inlay with application of MMC appears to be showing good efficacy, safe and effective in reducing corneal haze.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented, research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented